Skip to main content

Table 2 Patterns of glucose profiles by drug group (No./%)

From: Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension

 

β-blockers

Thiazide

CCBs

RAS

Others

P (χ2)

Glucose (mmol/l)

(n = 280)

(n = 180)

(n = 291)

(n = 50)

(n = 296)

 

Desirable (≤ 6.0)

236 (84.3)

153 (85.0)

253 (86.9)

42 (84.0)

229 (77.4)

0.849

Borderline (6.1–6.9)

35 (12.5)

22 (12.2)

28 (9.6)

5 (10.0)

59 (19.9)

 

Adverse (≥ 7.0)

9 (3.2)

5 (2.8)

10 (3.4)

3 (6.0)

8 (2.7)

 
  1. (CCB: Calcium channel blockers; RAS: drugs acting on the rennin angiotensin system.
  2. Glucose levels for desirable: ≤ 6.0 mmol/l, borderline: 6.1–6.9 mmol/l; adverse: ≥ 7.0 mmol/l)
Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904